Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab ; volume:11 ; number:3 ; year:2020 ; pages:652-657
Case reports in ophthalmology ; 11, Heft 3 (2020), 652-657
- Urheber
-
Britton, Anna Krystyna
Crayford, Basil Bamford
- DOI
-
10.1159/000510114
- URN
-
urn:nbn:de:101:1-2021011323310131264061
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Britton, Anna Krystyna
- Crayford, Basil Bamford
Ähnliche Objekte (12)
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity